OMEPRAZOLE

Product NDC
61919-847
11-digit product format
619190847
Labeler code
61919
Product ID
61919-847_c1c31f1c-23b7-6193-e053-2995a90abc73
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
OMEPRAZOLE
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Labeler
Direct Rx
Application
ANDA091672
Marketing category
ANDA
Marketing start
2020-08-12
Marketing end
0000-00-00
Substance
OMEPRAZOLE
Active strength
40 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
KG60484QX9OMEPRAZOLE73590-58-6OMEPRAZOLE

Packages

Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
61919-847-306191908473030 CAPSULE, DELAYED RELEASE in 1 BOTTLE (61919-847-30) 2020-08-120000-00-00NoNoCurrent
61919-847-606191908476060 CAPSULE, DELAYED RELEASE in 1 BOTTLE (61919-847-60) 2020-08-120000-00-00NoNoCurrent
61919-847-906191908479090 CAPSULE, DELAYED RELEASE in 1 BOTTLE (61919-847-90) 2020-08-120000-00-00NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
OMEPRAZOLE DRDirect Rx2023-05-31HUMAN PRESCRIPTION DRUG LABEL14